Sensorineural Deafness Following Tacrolimus Use
Early trials of tacrolimus in renal transplant recipients have not revealed hearing loss as an adverse effect. Here, we present a case report and a review of the literature of deafness after tacrolimus use. The review of the literature and our experience suggested that the possible reason for hearin...
Saved in:
Published in: | Experimental and clinical transplantation Vol. 18; no. 1; pp. 110 - 111 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Başkent Üniversitesi
01-02-2020
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Early trials of tacrolimus in renal transplant recipients
have not revealed hearing loss as an adverse effect.
Here, we present a case report and a review of the
literature of deafness after tacrolimus use. The review
of the literature and our experience suggested that the
possible reason for hearing loss could be due to an
initiation of a sudden spike in the tacrolimus serum
level, which was later worsened by its cumulative toxic
effect. |
---|---|
ISSN: | 1304-0855 2146-8427 |
DOI: | 10.6002/ect.2017.0114 |